Oncomine Focus Assay
A targeted NGS panel that identifies clinically actionable genomic alterations across 52 cancer-related genes, including SNVs, indels, CNVs, and gene fusions, enabling fast, precise profiling to support personalized cancer treatment decisions.
Clinical Insight
Focused Genomic Profiling
The Oncomine Focus Assay is a targeted next-generation sequencing panel built to detect clinically actionable alterations across 52 genes commonly implicated in solid tumors. Designed for speed, this assay delivers results from a single FFPE tissue sample while capturing single nucleotide variants, insertions and deletions, structural DNA changes, and gene fusions relevant to treatment selection.
Its compact, curated gene set suits laboratories seeking rapid turnaround without compromising clinical relevance. By focusing on genes with established therapeutic significance, the assay helps oncologists quickly identify actionable biomarkers, supporting timely, informed decisions in personalized cancer care where speed matters as much as accuracy.
Clinical Applications
Identifies single nucleotide variants across 52 cancer-related genes, pinpointing clinically relevant point mutations that inform targeted treatment selection and therapy planning decisions.
Clinical Applications
Detects insertions and deletions within key cancer genes, capturing structural changes that may drive tumor growth, progression, and response to targeted therapies.
Screens for gene amplifications and deletions, identifying structural DNA changes associated with tumor development, progression, and potential treatment resistance mechanisms.
Detects clinically significant gene fusions, uncovering chromosomal rearrangements that can serve as actionable targets for precision-based cancer therapy selection.
Testing Benefits
Focused Testing Faster Treatment Decisions
Fast Targeted Profiling
Delivers rapid genomic results by focusing on a curated 52-gene panel, enabling quicker turnaround than broader comprehensive profiling assays.
Actionable Biomarker Detection
Identifies clinically actionable alterations across SNVs, indels, CNVs, and gene fusions, giving oncologists relevant data for treatment planning.
Supports Treatment Decisions
Provides genomic insights that directly inform personalized cancer treatment strategies, helping clinicians select therapies suited to each tumor.
Curated Gene Selection
Focuses on 52 genes with established clinical relevance, streamlining analysis without the complexity of broader genomic panels.
Single-Sample Testing
Analyzes FFPE tissue samples using Ion Torrent NGS technology, conserving specimen material while capturing multiple alteration types.
Solid Tumor Applicability
Designed for solid tumor profiling, making it suitable across a range of cancer types requiring targeted molecular analysis.
Schedule Your Test
Our team supports fertility clinics and IVF centers with accurate, scalable embryo screening solutions nationwide today.
